NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 312 filers reported holding NOVOCURE LTD in Q4 2021. The put-call ratio across all filers is 0.86 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $233,945 | -52.1% | 3,890 | -41.6% | 0.17% | -54.9% |
| Q4 2022 | $488,511 | -3.5% | 6,660 | 0.0% | 0.38% | -9.5% |
| Q3 2022 | $506,000 | +12.7% | 6,660 | +3.1% | 0.42% | +15.7% |
| Q2 2022 | $449,000 | -14.1% | 6,460 | +2.4% | 0.36% | +5.2% |
| Q1 2022 | $523,000 | +21.1% | 6,310 | +9.6% | 0.34% | +28.4% |
| Q4 2021 | $432,000 | -35.4% | 5,755 | 0.0% | 0.27% | -39.8% |
| Q3 2021 | $669,000 | -49.4% | 5,755 | -3.4% | 0.44% | -48.7% |
| Q2 2021 | $1,321,000 | – | 5,955 | – | 0.87% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 350,884 | $26,344,000 | 8.01% |
| HARTLINE INVESTMENT CORP/ | 318,109 | $23,884,000 | 3.27% |
| Deep Track Capital, LP | 550,000 | $41,294,000 | 2.92% |
| MORGAN JESS S & CO INC | 43,975 | $3,302,000 | 2.03% |
| Taylor Frigon Capital Management LLC | 46,376 | $3,482,000 | 1.09% |
| Darsana Capital Partners LP | 258,937 | $19,441,000 | 0.90% |
| Private Harbour Investment Management & Counsel, LLC | 13,562 | $1,018,000 | 0.81% |
| Rhenman & Partners Asset Management AB | 120,387 | $9,610,000 | 0.64% |
| COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $751,000 | 0.50% |
| Baillie Gifford | 9,615,168 | $721,906,000 | 0.40% |